This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. rose 4.6% to $2.04 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 21,544.27 and the Dow Jones Industrial Average rising 0.3% to 45,418.07.
Inovio Pharmaceuticals Inc. closed 73.2% below its 52-week high of $7.61, which the company reached on August 27th.
The stock outperformed some of its competitors, as Johnson & Johnson fell 0.4% to $176.49, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.88% to $24.92.
Trading volume totaled 1.6 million, compared to the 50-day average of 2.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 26, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.